Who are we?
We bring a dedicated operational team, supported by a group of key specialist advisors
We have a network of dedicated scientific advisors. Their purpose is to support TIRmed Pharma with specialist knowledge that further our pre-clinical and clinical studies
Assoc. Prof. Mohammad Alimohammadi
Provides clinical expertise and is engaged in strategic design of clinical trials, risk management and pharmocovigilance.
Nicolaas Schipper, PhD
Head of manufacture at RISE (Research Institutes of Sweden) and leads their GMP production facilities in Södertälje. His expertise is in pharmaceutical development from early preclinic to marketed drug formulations and life cycle management. He has a PhD in pharmaceutics and (co) authored numerous articles and patents within the field of drug formulation, drug delivery, and drug absorption.
Betsy Hughes, PhD
Strategic & Clinical advisor
25+ years in the clinical development of a wide range of dermatology products. Previous leadership position in in a niche CRO specialized in conduct of early phase dermatological studies.
Anders Carlsson, PhD
20+ years experience in formulations of complex compounds. Specialist in pharmaceutical development of topical, oral and parenteral formulations.
Pirkko Tamsen, PhD
30+ years experience within life science, with multiple leadership positions of pharma SMEs as well as CROs. Experiences from large pharma such as Astra.
Anneli Hällgren, PhD
15+ years of pre-clinical development, supporting in strategic and practical development of pre-clinical formulation and project development.
Anders Neil, PhD
30 years experience in leading scientific roles within bioscience. Specialist regulatory knowledge in pharmacology, toxicology and drug development.
Former consultant at BCG. Strategy specialist, with experiences as advisor for multiple pharma deals and large strategic projects. Previously engaged in raising capital in SME settings. Masters from London Business School.
Prof. Anna-Lena Spetz
25+ years in immunology research, With previous experiences from Karolinska Institutet, Institut Pasteur, and Dana-Farber Cancer Institute, Harvard Medical School. Previous SME experiences as a project leader, co-founder and board member in Avaris AB (2001-2012)